This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Medical Practice  • Medical Practice, Other  • Cardiovascular System  • Prognosis/ Outcomes  • Congestive Heart Failure/ Cardiomyopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

Mike Mitka

JAMA. 2009;301(22):2317.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Orlando, Fla—Heart failure causes about 300 000 deaths annually in the United States, yet progress in treating it remains frustratingly slow, according to researchers speaking at the scientific sessions of the American College of Cardiology (ACC) meeting held here in March.

Although patients admitted with acute heart failure syndromes appear to improve during hospitalization, they have high postdischarge mortality and readmission rates. This situation results, in part, because of underutilization of many effective therapies. About 20% of patients diagnosed as having heart failure die within a year. Among patients older than 65 years, it is the most common diagnosis at hospital discharge and the primary cause of readmission within 60 days of leaving the hospital (Shah SJ and Gheorghiade M. JAMA. 2008;300[4]:431-433). The American Heart Association estimates the direct and indirect cost of heart failure for 2009 at more than $37 billion, with a significant portion reflecting . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?